New blood analyzer feature aims to catch sample damage
NCT ID NCT07345091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new hemolysis detection feature on the ABL90 FLEX PLUS HEM blood gas analyzer. Hemolysis (damage to red blood cells) can skew test results. Researchers will collect blood samples from 95 adults and check if the device correctly flags damaged samples. The goal is to improve the reliability of blood test results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ABL90 FLEX PLUS HEM device (blood gas analyzer with hemolysis detection feature)
What this could lead to
If successful, this could make blood test results more reliable by automatically flagging damaged samples.
What could go wrong
This is a small feasibility study (95 participants) testing a device feature, not a treatment. It may not prove the feature works in all real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bispebjerg Hospital
RECRUITINGCopenhagen, NV, 2400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••